Terns Pharmaceuticals Inc's Customers Performance

Name: Terns Pharmaceuticals Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

TERN

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


TERN's Source of Revenues		• List of TERN Customers

for the same period Terns Pharmaceuticals Inc

• List of TERN Customers

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Terns Pharmaceuticals Inc's Comment on Sales, Marketing and Customers

News about Terns Pharmaceuticals Inc Contracts

Strategic Talent Acquisition in Biopharmaceuticals The Role of Equity Inducement Awards at Terns Pharmaceuticals ...

Equity Inducement Award Practices: A Case Study of Terns PharmaceuticalsIn the constantly evolving field of biopharmaceuticals, the development and retention of top-tier talent are critical for maintaining competitive edge and driving innovation. Recognizing the importance of strategic human resource practices, Terns Pharmaceuticals, Inc., a prominent clinical-stage biopharmaceutical company, has recently announced the allocation of equity inducement awards to a key executive under the company s 2022 Employment Inducement Award Plan. This article examines the details of this initiative and its broader implications within the industry. Appointment and Inducement AwardsOn August 1, 2024, Terns Pharmaceuticals...

Empowering Innovation: Terns Pharmaceuticals Leverages Equity Inducements to Attract Top Talent

: Terns Pharmaceuticals, Inc. (Nasdaq: TERN), a company at the forefront of developing innovative small molecule therapeutics, has recently announced the grant of equity inducement awards to new employees under the 2022 Employment Inducement Award Plan, as amended. This strategic move is aimed at attracting top-tier talent to bolster the company s research and development efforts, particularly in the fields of oncology and obesity. The grants, approved by the Compensation Committee of the Board of Directors, adhere to Nasdaq Listing Rule 5635(c)(4) and are a testament to the company’s commitment to growth and innovation. In the highly competitive biopharmaceutical sector, attracting and retaining top tal...

TERN's Stock Performance relative to it's Customers

TERN's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Terns Pharmaceuticals Inc	4,933.17	0.00	-94.44	59
SUBTOTAL	0.00	0.00	0.00	-

Sources: Terns Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Terns Pharmaceuticals Inc’s corporate clients.
For your research, we’ve provided 9 tables on Terns Pharmaceuticals Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.